Gri Bio Inc (GRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GRI | AMGN | VRTX | REGN | GILD |
| Company | Gri Bio Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.7000 | 317.06 | 487.34 | 1,057.17 | 67.83 |
| High | 1.7500 | 322.88 | 491.76 | 1,072.33 | 68.86 |
| Low | 1.5100 | 314.64 | 485.77 | 1,053.28 | 67.65 |
| Last | 1.6200 | 321.67 | 491.62 | 1,071.12 | 68.75 |
| Change | -0.2000 | +5.76 | +5.63 | +17.09 | +0.99 |
| % Change | -10.99% | +1.82% | +1.16% | +1.62% | +1.46% |
| Volume | 337,100 | 2,192,100 | 855,000 | 263,900 | 4,101,500 |
| 20-Day Average Volume | 328,152 | 2,335,400 | 1,191,430 | 477,640 | 8,607,475 |
| Previous Close | 1.8200 | 315.91 | 485.99 | 1,054.03 | 67.76 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.3558 | 309.69 | 475.58 | 1,046.34 | 67.29 |
| 20-Day Raw Stochastic | 7.80% | 85.56% | 99.51% | 87.94% | 63.88% |
| 20-Day Relative Strength | 27.22% | 63.79% | 67.89% | 64.88% | 55.40% |
| Weighted Alpha | -98.43 | +38.64 | +44.22 | +47.95 | -11.85 |
| Today's Opinion | 100% Sell | 100% Buy | 100% Buy | 100% Buy | 40% Sell |
| Previous Opinion | 100% Sell | 100% Buy | 100% Buy | 100% Buy | 40% Sell |
| Last Month's Opinion | 100% Sell | 72% Buy | 88% Buy | 88% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.22% since 07/02/24 | +3.51% since 07/02/24 | +3.77% since 07/02/24 | +2.53% since 07/02/24 | +0.51% since 07/02/24 |
| Low | 1.4600 on 07/05/24 | 306.11 on 07/03/24 | 466.01 on 07/03/24 | 1,011.67 on 07/03/24 | 66.01 on 07/05/24 |
| High | 1.9399 on 07/09/24 | 322.88 on 07/10/24 | 491.76 on 07/10/24 | 1,072.33 on 07/10/24 | 68.86 on 07/10/24 |
| 1-Month | |||||
| %Chg | -52.98% since 06/10/24 | +5.56% since 06/10/24 | +1.73% since 06/10/24 | +6.93% since 06/10/24 | +5.36% since 06/10/24 |
| Low | 1.4600 on 07/05/24 | 295.30 on 06/13/24 | 463.23 on 06/20/24 | 997.84 on 06/11/24 | 62.69 on 06/18/24 |
| High | 3.5100 on 06/12/24 | 326.12 on 06/25/24 | 491.76 on 07/10/24 | 1,081.17 on 06/25/24 | 72.18 on 06/21/24 |
| 3-Month | |||||
| %Chg | -76.31% since 04/10/24 | +20.72% since 04/10/24 | +23.65% since 04/10/24 | +14.41% since 04/10/24 | +0.92% since 04/10/24 |
| Low | 1.4600 on 07/05/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 7.6700 on 04/19/24 | 326.12 on 06/25/24 | 491.76 on 07/10/24 | 1,081.17 on 06/25/24 | 72.18 on 06/21/24 |
| 6-Month | |||||
| %Chg | -94.52% since 01/10/24 | +5.61% since 01/10/24 | +16.01% since 01/10/24 | +18.20% since 01/10/24 | -18.64% since 01/10/24 |
| Low | 1.4600 on 07/05/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 65.0000 on 01/30/24 | 329.72 on 02/05/24 | 491.76 on 07/10/24 | 1,081.17 on 06/25/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 990 | 169,465,184 | 125,411,184 | 116,139,344 | 84,419,000 |
| Shares Outstanding, K | 544 | 536,435 | 258,053 | 110,186 | 1,245,853 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 27,116,000,000 |
| Annual Net Income | -13,040,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 6,686,000,000 |
| Last Quarter Net Income | -1,890,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -4,170,000,000 |
| 60-Month Beta | -1.68 | 0.58 | 0.39 | 0.13 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -5.98 on 05/10/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -1.32 on 04/25/24 |
| Latest Earnings Date | 08/12/24 | 08/06/24 | 08/01/24 | 08/01/24 | 08/08/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.770 on 06/14/24 |
| Next Ex-Dividends Date | 12/19/19 | 05/16/24 | N/A | N/A | 06/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.72 | 32.00 | 28.35 | 16.76 |